视网膜色素炎的遗传疗法:目前的突破和未来的方向
Zofia Pniakowska1,2, Natasza Dzieża1, Natalia Kustosik1
1Department of Ophthalmology and Vision Rehabilitation, Medical University of Lodz, 90-549 Lodz, Poland.
Journal of clinical medicine
|August 28, 2025
概括
视网膜色素炎 (RP) 的治疗方法正以针对特定突变的基因疗法和光遗传学等新方法进步. 这些创新策略为患有遗传性视网膜疾病的患者提供了希望.
科学领域:
- 眼科 眼科
- 遗传学
- 分子生物学
背景情况:
- 皮质视网膜炎 (RP) 是一组遗传性视网膜疾病,由于光受体细胞死亡而导致逐渐的视力丧失.
- 在全球范围内,RP影响着约4000个个体中的1个,并且在遗传上异质,涉及RHO,PRPF31,RPE65,USH2A和NR2E3等基因的突变.
- 目前的治疗重点是控制症状,对有针对性的治疗越来越需要.
研究的目的:
- 审查视网膜色素炎的遗传基础.
- 探索基因基因和其他先进的治疗策略.
- 强调在治疗遗传性视网膜疾病方面转向精准医学.
主要方法:
- 对RP遗传学和治疗开发的最新文献的审查.
- 对基因疗法 (Luxturna,OCU400,QR-1123,SPVN06),光遗传疗法 (MCO-010) 和基因组编辑 (CRISPR-Cas) 的分析.
- 对临床试验结果和临床前发现进行讨论.
主要成果:
- 卢克斯图纳是第一个获得FDA批准的针对RPE65突变的基因疗法.
- OCU400和SPVN06分别提供基因独立和突变无关的方法.
- 对于特定的RHO突变,QR-1123显示有前途,而MCO-010则提供了独立于途径的治疗方法.
- 在未来,CRISPR-Cas技术将为个性化突变纠正提供潜力.
结论:
- 在开发针对性治疗视网膜色素炎方面取得了重大进展.
- 基因疗法,光遗传学和基因组编辑等创新疗法正在改变RP管理.
- 这一领域正朝着针对遗传性视网膜疾病的个性化,突变特异性干预方向发展,
更多相关视频
07:04Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
Published on: February 4, 2021
2.1K
06:48Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
21.5K
相关概念视频
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Gene Therapy
25.8K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.8K
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
